Indication 

Anovulation women who have no response under the therapy of clomiphene citrate (including PCOS, polycystic ovary syndrome).

Highlights

High quality

Produced in efficient mammalian cell expression system

Higher purity and bioactivity, better efficacy compared with uhFSH (urine sourced)

Clinical trial Phase III, compared with GONAL-f of Merck (Schweiz) AG, similar clinical efficacy with GONAL-f.

Dosage Form 

Loose white powder

Potential Clinical Indication

 Anovulation infertility

Specification

75IU (5.5μg)/ 1.0ml/ vial